Artificial Intelligence Integration With Nanotechnology for Cancer Therapy
Shengbin Liu, Zhi Liu, Haixing Shi, Chengyi Wei, Ruijie Zhang, Xiangrong Song · 2026
Read Artificial Intelligence Integration With Nanotechnology for Cancer Therapy by Shengbin Liu, Zhi Liu, Haixing Shi, Chengyi Wei, Ruijie Zhang, Xiangrong Song (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13527537.txt.
Description
Liu and five co-authors review how artificial intelligence can join with nanotechnology for cancer therapy in a 2026 paper. Cancer nanomedicine can improve how drugs act, but results in the body are hard to predict. Design has often relied on trial and error.
The review covers AI-guided material design, targeting, payload choice, and delivery in the body. Special topics include the protein corona that forms on particles and models of where particles spread. The authors also discuss what translation to clinics needs, such as standard data and risk-based rules. Future directions include learning systems that transfer across cases and patient-aware strategies. The aim is more predictive nanomedicine.
Catalog record
| CREATOR | Shengbin Liu, Zhi Liu, Haixing Shi, Chengyi Wei, Ruijie Zhang, Xiangrong Song |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |